DHAN KAUSHAL, MD
3730 S EASTERN AVE, LAS VEGAS, NV 89169
NPI Number
1730186354
Practice location · View on Google Maps
Total Medicaid Payments
$82,046
-78% vs specialty average
Patients Seen
887
Total Claims
1,011
$ Per Patient
$92
Specialty avg: $39
Specialty Rank
#5 of 40
Internal Medicine, Hematology & Oncology providers in Nevada
Peer Average
$369,448
Average total for Internal Medicine, Hematology & Oncology
Claims per Patient
1.1
Average visits / services per person
Payments by Year
How much Medicaid paid this provider each year. Large jumps can indicate changes in practice volume or billing patterns.
| Year | Total Paid | % of Max |
|---|---|---|
| 2018 | $82,046 |
Procedure Code Breakdown
The specific medical services this provider billed Medicaid for. Each HCPCS/CPT code represents a different type of visit, test, or treatment.
| HCPCS Code | Description | Claims | Paid | % of Total | Avg per Claim |
|---|---|---|---|---|---|
| 99214 | Office visit for a moderate problem (established patient) | 556 | $54,672 | 66.6% | $98 |
| J1756 | Injection, iron sucrose, 1 mg | 79 | $10,976 | 13.4% | $139 |
| 96365 | IV infusion of medication — giving medicine through an IV (first hour) | 133 | $7,934 | 9.7% | $60 |
| 99204 | New patient office visit — detailed visit for a serious problem | 41 | $6,223 | 7.6% | $152 |
| 85025 | Complete blood count (CBC) — checks red cells, white cells, and platelets | 141 | $1,056 | 1.3% | $7 |
| 96375 | IV push — additional medication through an IV | 16 | $624 | 0.8% | $39 |
| 82728 | Blood chemistry test (checking specific substances in your blood) | 28 | $377 | 0.5% | $13 |
| 80053 | Comprehensive metabolic panel blood test (checks liver, kidney, blood sugar, electrolytes) | 17 | $184 | 0.2% | $11 |
About This Data
This data comes from the HHS Medicaid Provider Spending dataset (opendata.hhs.gov). It shows payments made through Nevada Medicaid from 2018–2024. High payments do not mean a provider is doing anything wrong — some specialties naturally cost more, and busy providers see more patients. But unusually high numbers compared to peers can be worth a closer look.